Mumbai: India Inc was less generous with dividends in FY24 than in previous 9 years amid an increase in capital expenditure with average capacity utilisation exceeding the long-term average. The …
Most technical charts and options data hint at a bullish setup. According to technical analysts, Nifty is expected to continueits upward trajectory towards 23,560, followed by 23,890, with immediate support …
Shares of Sun Pharmaceutical Industries fell 5% in Thursday’s trade on BSE to the day’s low of Rs 1,467 even after the company posted a 34% year-on-year (YoY) jump in …
“I do not think the market is bracing for any kind of negative surprise at this point of time. And we do think that given the earnings that we have …
Benchmark indices closed higher on Wednesday amid buying in blue chips even on the back of mixed cues from global markets. The 30-share Sensex climbed 267 points to settle at …
Various widely tracked companies like ITC, ONGC, IRFC, Ircon International, BHEL, BEL, Sun Pharma, Nykaa, Tata Investment Corporation, Hindalco, Ashok Leyland, and Divi’s lab will be releasing their March quarter …
May 09, 2024, 03:32:49 PM IST Around 10 companies witnessed the highest selling by mutual funds in March, according to a press release by Prime database. Here is the detailed …
Technical charts indicate that Nifty and Bank Nifty are currently poised for an upward trend. According to technical analysts, Nifty may ascend towards 22,800 levels, while Bank Nifty could touch …
Brokerage firm HSBC maintained a buy rating on Sun Pharma, Citigroup recommended a buy rating on ICICI Bank, JPMorgan has an overweight rating on Bajaj Finance and CLSA recommended a …
Technical analysts continue to maintain a cautious outlook on Nifty for the truncated trading week ahead. According to analysts, profit-taking may resume until the index decisively reclaims 22,200. Some of …